Actively Recruiting
Cardiovascular Prevention Supported by Digital Technology: Comparison With the Traditional Model
Led by Maria Cecilia Hospital · Updated on 2026-05-27
144
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Cardiovascular diseases are a leading cause of illness and death globally. This research aims to compare the effectiveness and feasibility of a cardiovascular prevention program delivered remotely via a digital app against traditional in-person care. The study focuses on patients at cardiovascular risk to help reduce events and slow disease progression. Participants will be randomly assigned to one of two groups: one using remote management through a digital application to collect follow-up information, and another receiving traditional in-person follow-up at a hospital. The intervention involves providing recommendations to patients and monitoring their health through these different care pathways. During the study, participants will be followed for up to 24 months with regular assessments. Researchers will measure blood pressure at 12 months and track cigarette use, body weight, and daily steps over 24 months. The study monitors adherence to the assigned care model and evaluates health outcomes at scheduled follow-up visits.
CONDITIONS
Brief Title
Cardiovascular Prevention Supported by Digital Technology: Comparison With the Traditional Model
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 40 and 75 years
- Diagnosis of hypertension
- Presence of hyperglycaemia
- Type 2 diabetes without insulin therapy
- Diagnosis of dyslipidaemia
- Active smoking habit
- Overweight or grade I obesity
- Willingness to attend follow-up visits over 24 months
You will not qualify if you...
- Previous myocardial infarction
- History of stroke
- Transient ischemic attack
- Coronary artery disease
- Peripheral arterial occlusive disease
- Heart failure
- Type 1 or type 2 diabetes on insulin therapy
- Advanced chronic kidney disease (eGFR < 30 mL/min/1.73 m²)
- Active cancer
- Severe obesity
- Inability to use digital tools
- Pregnancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 24 months
Participants receive recommendations to manage cardiovascular risk factors, either remotely using digital technology or through in-person follow-up at the hospital.
Regular follow-up visits over 24 months either remotely or in-person depending on assigned group
Trial Site Locations
Total: 1 location
1
Maria Cecilia Hospital
Cotignola, Ravenna, Italy, 48033
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here